And the award goes to Cerebiome!
Frost & Sullivan identifies Lallemand’s Cerebiome® as the world’s most proven psychobiotic. Read
CEREBIOME® capacity to increase brain-derived neurotrophic factor levels translate from preclinical to clinical study
A new post-hoc analysis confirmed in humans that CEREBIOME® can increase significantly BDNF serum levels as observed several years ago in preclinical models. These new results bring more understanding about the potential modes of action of CEREBIOME® on the gut-brain axis, especially on depressive population. Read
Exciting clinical work on depression
Ms. Wallace’s presentation “Bridging the Gap between Nutrition and Psychiatry Using Probiotics” examines the effects of probiotics supplements on symptoms of depression employing a combination of Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175, developed by Lallemand Health Solutions. Read
The first psychobiotic in Korea
“Probiotiques Détente” (프로바이오티끄 디땅트), is produced by Lallemand Health Solutions and will be exported to Korea for the first time in March. Read
First psychobiotic in Brazil: ANVISA approved claims stress & anxiety
Probiotic combination of L. helveticus Rosell®-52 and B. longum Rosell®-175, first to be recognized for its specific benefits in stressed healthy adults by ANVISA in brazil Read